This study compared the effectiveness of two concentrations of dexamethasone administered via intratympanic injection for treating idiopathic sudden sensorineural hearing loss. The researchers found that 4 mg/mL and 10 mg/mL dexamethasone provided similar hearing improvement when injected intratympanically. Both concentrations led to significantly better hearing outcomes compared to no injection.
This study compared the effectiveness of two concentrations of dexamethasone administered via intratympanic injection for treating idiopathic sudden sensorineural hearing loss. The researchers found that 4 mg/mL and 10 mg/mL dexamethasone provided similar hearing improvement when injected intratympanically. Both concentrations led to significantly better hearing outcomes compared to no injection.
This study compared the effectiveness of two concentrations of dexamethasone administered via intratympanic injection for treating idiopathic sudden sensorineural hearing loss. The researchers found that 4 mg/mL and 10 mg/mL dexamethasone provided similar hearing improvement when injected intratympanically. Both concentrations led to significantly better hearing outcomes compared to no injection.
Intratympanic Injection of Dexamethasone 4 mg/mL versus 10 mg/mL
for Management of Idiopathic Sudden Sensorineural Hearing Loss. The Egyptian Journal of Otolaryngology. The Egyptian Journal of Otolaryngology. 2020; 36 (3): 1-6